Maria G Fencer Catherine H Davis Jieqi Liu Mark A Galan Kristen R Spencer
10.1177/23247096221129470
J Investig Med High Impact Case Rep
2022 Jan-Dec;10:23247096221129470.
atezolizumab bevacizumab hepatocellular carcinoma sarcomatoid
CC BY-NC
https://pubmed.ncbi.nlm.nih.gov/36541195/
Carcinoma, Hepatocellular / drug therapy Liver Neoplasms / drug therapy
Carcinoma, Hepatocellular / drug therapy Liver Neoplasms / drug therapy Case Reports Antibodies, Monoclonal, Humanized / therapeutic use Bevacizumab / therapeutic use Humans Bevacizumab atezolizumab Antibodies, Monoclonal, Humanized
PMC9791267
36541195
Disease Control Achieved Using Atezolizumab + Bevacizumab in a Patient With Sarcomatoid Hepatocellular Carcinoma (SHCC), a Rare Variant Excluded From the IMbrave150 Trial
2022